Oakworth Capital Inc. reduced its stake in Monsanto (NYSE:MON) by 10.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,591 shares of the basic materials company’s stock after selling 424 shares during the period. Oakworth Capital Inc.’s holdings in Monsanto were worth $425,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of MON. Thrivent Financial For Lutherans boosted its stake in shares of Monsanto by 2.3% in the 2nd quarter. Thrivent Financial For Lutherans now owns 16,628 shares of the basic materials company’s stock valued at $1,968,000 after purchasing an additional 371 shares in the last quarter. Columbia Partners L L C Investment Management boosted its stake in shares of Monsanto by 3.7% in the 2nd quarter. Columbia Partners L L C Investment Management now owns 37,547 shares of the basic materials company’s stock valued at $4,444,000 after purchasing an additional 1,338 shares in the last quarter. New York State Common Retirement Fund boosted its stake in shares of Monsanto by 0.7% in the 2nd quarter. New York State Common Retirement Fund now owns 1,166,025 shares of the basic materials company’s stock valued at $138,011,000 after purchasing an additional 7,746 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in shares of Monsanto by 1.7% in the 2nd quarter. Mutual of America Capital Management LLC now owns 53,567 shares of the basic materials company’s stock valued at $6,340,000 after purchasing an additional 909 shares in the last quarter. Finally, UBS Asset Management Americas Inc. boosted its stake in shares of Monsanto by 15.8% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,526,644 shares of the basic materials company’s stock valued at $299,054,000 after purchasing an additional 345,554 shares in the last quarter. Institutional investors own 75.41% of the company’s stock.

Shares of Monsanto (NYSE:MON) traded down $0.24 during midday trading on Monday, reaching $120.42. 172,288 shares of the company were exchanged, compared to its average volume of 3,240,000. The company has a market cap of $53,010.00, a price-to-earnings ratio of 22.26, a PEG ratio of 1.73 and a beta of 1.04. Monsanto has a 1-year low of $106.97 and a 1-year high of $122.79. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.

Monsanto (NYSE:MON) last released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 10.34% and a net margin of 6.40%. The firm had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the previous year, the business posted $0.21 EPS. The firm’s revenue for the quarter was up .3% compared to the same quarter last year. analysts predict that Monsanto will post 5.76 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.79%. Monsanto’s payout ratio is 39.93%.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.70% of the stock is currently owned by company insiders.

A number of brokerages recently issued reports on MON. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a report on Thursday, October 5th. Barclays reiterated an “equal weight” rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Wells Fargo & Co raised their price objective on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Monsanto has an average rating of “Hold” and a consensus price target of $127.30.

ILLEGAL ACTIVITY WARNING: “Monsanto (MON) Shares Sold by Oakworth Capital Inc.” was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2018/01/22/monsanto-mon-shares-sold-by-oakworth-capital-inc.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.